Actively Recruiting
Chinese American Cancer Survivors Writing Study
Led by New York University · Updated on 2025-12-09
108
Participants Needed
1
Research Sites
233 weeks
Total Duration
On this page
Sponsors
N
New York University
Lead Sponsor
N
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.
CONDITIONS
Official Title
Chinese American Cancer Survivors Writing Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years old
- Prefer speaking in Mandarin Chinese or Cantonese, and able to read and write Simplified or Traditional Chinese
- Within 5 years after completing primary treatment or have completed primary treatment but still on medication for managing cancer-related symptoms
You will not qualify if you...
- Difficulties with writing
- Current active participation in support groups (i.e., attending more than once per week)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
New York University
New York, New York, United States, 10003
Actively Recruiting
Research Team
W
William Tsai, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here